tiprankstipranks
Trending News
More News >
Arch Biopartners (TSE:ARCH)
:ARCH
Canadian Market

Arch Biopartners (ARCH) Income Statement

Compare
38 Followers

Arch Biopartners Income Statement

Last quarter (Q3 2025), Arch Biopartners's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Arch Biopartners's net income was C$-242.33K. See Arch Biopartners’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 2.12MC$ 1.98MC$ 964.68KC$ 3.89MC$ 67.89K
Gross Profit
C$ -1.66MC$ -129.00KC$ -503.00KC$ -150.00KC$ -2.12M
Operating Expenses
C$ 2.29MC$ 3.35MC$ 1.08MC$ 1.17MC$ 2.51M
Depreciation and Amortization
C$ 3.46MC$ 2.90MC$ 997.10KC$ 819.38KC$ 4.38M
EBITDA
C$ -3.53MC$ -336.00KC$ -101.00KC$ -77.02KC$ -4.45M
Operating Income
C$ -3.95MC$ -3.35MC$ -1.39MC$ -1.17MC$ -4.63M
Other Income/Expenses
C$ 26.82KC$ 28.43KC$ -18.49KC$ -4.86KC$ 5.43K
Pretax Income
C$ -3.92MC$ -3.33MC$ -1.41MC$ -1.17MC$ -4.63M
Net Income
C$ -3.92MC$ -3.33MC$ -1.41MC$ -1.17MC$ -4.63M
Per Share Metrics
Basic EPS
C$ -0.06C$ -0.05C$ -0.02C$ -0.02C$ -0.08
Diluted EPS
C$ -0.06C$ -0.05C$ -0.02C$ -0.02C$ -0.08
Weighted Average Shares Outstanding
63.38M 62.47M 62.16M 61.32M 59.92M
Weighted Average Shares Outstanding (Diluted)
63.38M 62.47M 62.16M 61.32M 59.92M
Currency in CAD

Arch Biopartners Earnings and Revenue History